secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0000950170-24-060084
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix enters $15M at-the-market equity offering with H.C. Wainwright
------------------------------------------------------------------------

- Company may sell ADSs with aggregate offering price up to $15M on Nasdaq through H.C. Wainwright.
- Placement fee of 3% of gross sales; company reimburses certain agent expenses.
- Agreement effective May 15, 2024; no obligation to sell any ADSs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024060084/0000950170-24-060084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024060084/rnlx-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-060084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer